Epsilon-3 Bio's Seed VC Round

Epsilon-3 Bio raised a round of funding on , .

Epsilon-3 Bio is a preclinical stage company, developing compounds for chronic inflammatory and autoimmune disorders. The company's approach is targeting removal of cellular debris.…

Articles about Epsilon-3 Bio's Seed VC Round: